Author's Profile

Marina Temkin

Financial Writer

Marina Temkin covered the venture capital ecosystem from 2021 to 2024, based in San Francisco. Previously with Venture Capital Journal, Marina wrote about the VC industry, and she was a reporter with Mergermarket in New York and San Francisco. She also has been a financial analyst and is a CFA charterholder. Marina received an economics degree from the University of California, Davis, and she attended the CUNY Graduate School of Journalism.

m-temkin-low-res-round.png

Articles by Marina Temkin

JP Morgan wins First Republic; will it win over VCs and the startup world?

JP Morgan is buying First Republic, but it isn’t clear if the largest bank in the US will retain the specialty lender’s hands-on approach to customer care and support.
April 30, 2023

Micro-fund managers feel deflated as LPs cool on VC

Now that raising capital has become much harder amid rising interest rates, venture capital industry participants expect a chunk of micro-funds never to raise a subsequent vehicle. The widespread decline in exits means that emerging managers haven’t had a chance to prove themselves, and they may find the battle to raise funds isn’t worth the fight.
April 20, 2023

VCs expected an M&A wave. Dealmaking fell to a decade low instead.

Big acquirers are curtailing their shopping habits, a blow to startup founders and their investors.
April 18, 2023

Battle for gen AI pits startups against defending champs

Generative AI may be the next groundbreaking technology. But investing in it could be more challenging than in the previous tech revolutions.
April 13, 2023

Opportunity funds fall from favor as VCs go back to basics

As interest rates rose and publicly traded tech stocks plummeted last year, investing in mature startups became a lot less attractive. Late-stage investing has dropped, and early-stage investors suddenly found that fewer of their portfolio companies were on a path to receive large valuation step-ups. The result: Fewer opportunities for opportunity funds.
April 9, 2023

Reach Capital raises its largest fund ever despite edtech slowdown

Edtech-focused Reach Capital raised $215M fourth fund.
April 9, 2023

Cure Ventures debuts with $350M life sciences fund

Cure Ventures, a firm launched by biopharma veterans, has closed its inaugural $350 million fund for backing both novel drugs and medicines already undergoing clinical trials.
April 2, 2023

Torch announces $200M for funding consumer-facing startups

Torch Capital is announcing the closing of over $200 million across two funds: a $116 million second flagship fund and an $89 million first opportunity fund.
March 27, 2023

Exclusive: Tribeca raising $200M downturn-oriented VC growth fund

Since not all existing investors will want to participate in down rounds, Tribeca can use its growth fund to play the “bad guy” and set a lower price.
March 26, 2023

Why LPs think SVB’s failure has an upside

SVB’s disintegration makes VC even more vulnerable. LPs see benefits for the ecosystem—and their allocations.
March 23, 2023